Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
05/16/2012 | CN102458395A Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound |
05/16/2012 | CN102453658A Radde anemone rhizome health care wine capable of dispelling wind-evil and activating collaterals |
05/16/2012 | CN102453656A Health-care wine for dispelling wind and stimulating circulation of blood |
05/16/2012 | CN102451349A Production process for leek extractive |
05/16/2012 | CN102451262A Preparation method of Chinese medicinal prescription for treating hydrocele of tunica vaginalis |
05/16/2012 | CN102451233A Lichong oral liquid |
05/16/2012 | CN101934015B Traditional Chinese medicinal composition for treating thyroid and method for preparing dispelling-goitre cataplasm thereof |
05/16/2012 | CN101683353B Preparation method and application of flavone and flavan derivatives |
05/16/2012 | CN101282936B Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
05/16/2012 | CN101171266B Acerola fruit-derived pectin and use thereof |
05/15/2012 | US8178693 N3 alkylated benzimidazole derivatives as MEK inhibitors |
05/15/2012 | US8178663 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |
05/15/2012 | US8178543 Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors |
05/15/2012 | US8178499 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |
05/15/2012 | US8178493 Method for inducing angiogenesis in a heart of a patient |
05/15/2012 | US8178348 For preventing gene transcription/expression; for inducing nuclease stability, hybridization to complementary RNA sequences, permeability to oligonucleotides into cells, RNase cleavage, and blocking ribosome translocation |
05/15/2012 | US8178116 Methods and compositions for treating ectoparasite infestation |
05/15/2012 | CA2645558C Regulation of phospholipase d activity |
05/15/2012 | CA2536281C Ophthalmic composition comprising a 15-keto-prostaglandin compound |
05/15/2012 | CA2530374C Hsp90 family protein inhibitors |
05/15/2012 | CA2526361C Amide derivative |
05/15/2012 | CA2496329C Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
05/15/2012 | CA2493859C Preventive/remedy for arteriosclerosis comprising adiponectin |
05/15/2012 | CA2478223C Combinations comprising epothilone derivatives and alkylating agents |
05/15/2012 | CA2474964C An insulin improving agent containing adiponectin |
05/15/2012 | CA2470863C Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
05/15/2012 | CA2470500C Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
05/15/2012 | CA2464471C Method of treating depression with delta receptor agonist compounds |
05/15/2012 | CA2461227C Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
05/15/2012 | CA2439452C High-affinity antagonists of elr-cxc chemokines |
05/15/2012 | CA2430816C Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient |
05/15/2012 | CA2409286C Dog & cat food compositions having a probiotic lactobacillus strain |
05/15/2012 | CA2337082C Incorporation of exogenous lactic bacteria into the oral microflora |
05/15/2012 | CA2283642C Therapeutic compositions |
05/10/2012 | WO2012061597A1 Alpha-glucosidase binders and methods of their use |
05/10/2012 | WO2012060448A1 Combined pharmaceutical composition as antifungal agent |
05/10/2012 | WO2012060396A1 Trans-2-decenoic acid derivative and medicament containing same |
05/10/2012 | WO2012060388A1 Organic amine salt of aminobenzoic acid derivative, and method for producing same |
05/10/2012 | WO2012060323A1 Skin and hair color-controlling factor |
05/10/2012 | WO2012060308A1 Medicine for preventing and treating renal dysfunction |
05/10/2012 | WO2012058993A1 Use of ambrisentan for preventing or alleviating cardiac function injury caused by hypoxia |
05/10/2012 | WO2012058935A1 Total polysaccharides of radix isatidis and their fractions, and uses thereof as vaccine adjuvants |
05/10/2012 | WO2012024637A3 Ethyl pyruvate compositions and methods |
05/10/2012 | WO2012019428A8 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof |
05/10/2012 | WO2012019427A8 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof |
05/10/2012 | US20120117669 Human antibodies derived from immunized xenomice |
05/10/2012 | US20120115950 Abuse-resistant amphetamine prodrugs |
05/10/2012 | US20120115948 Inhibitors of anaphase promoting complex activity |
05/10/2012 | US20120115940 Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis |
05/10/2012 | US20120115921 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
05/10/2012 | US20120115893 Substituted Bicyclic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
05/10/2012 | US20120115854 Pharmaceutical composition containing antihypertensive agents |
05/10/2012 | US20120115824 Vitamin D Receptor Agonists and Uses Thereof |
05/10/2012 | US20120115229 Embryonic stem cells and neural progenitor cells derived therefrom |
05/10/2012 | US20120115136 Pna diagnostic use |
05/10/2012 | US20120114776 Methods for preparing probiotic nanoparticles |
05/10/2012 | US20120114760 Compositions for treating wounds and processes for their preparation |
05/10/2012 | US20120114717 Tableting agent having a low water content, and method for the production thereof |
05/10/2012 | US20120114708 Integrin heterodimer and an alpha subunit thereof |
05/10/2012 | US20120114697 Treatment of holocrine gland dysfunction with clostridia neurotoxins |
05/10/2012 | US20120114693 Nucleic acid mucosal immunization |
05/10/2012 | US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection |
05/10/2012 | US20120114679 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
05/10/2012 | US20120114570 Collagen extraction from aquatic animals |
05/10/2012 | CA2816670A1 Organic amine salts of aminobenzoic acid derivatives and method for producing same |
05/10/2012 | CA2815964A1 Trans-2-decenoic acid derivative and pharmaceutical agent containing the same |
05/10/2012 | CA2813411A1 Engineered polypeptide conjugates and methods for making thereof using transglutaminase |
05/09/2012 | EP2450374A1 Peptide and use thereof |
05/09/2012 | EP2450051A1 Medicinal agent and method for treatment of intractable chronic hepatitis c |
05/09/2012 | EP2448921A1 Aryl indole derivatives |
05/09/2012 | EP2448600A1 Compounds targeting the cation-independent mannose 6-phosphate receptor |
05/09/2012 | EP2213292B1 Double-stranded oligonucleotides |
05/09/2012 | EP1672062B1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis |
05/09/2012 | EP1609798B1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
05/09/2012 | EP1501467B1 Heterocyclo inhibitors of potassium channel function |
05/09/2012 | EP1492536B1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
05/09/2012 | EP1427830B1 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
05/09/2012 | EP1423107B1 Fatty alcohol drug conjugates |
05/09/2012 | EP1409506B1 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
05/09/2012 | EP1372610B1 Powder inhaler formulations |
05/09/2012 | EP1284963B1 Novel calcium receptor active molecules and method for preparing same |
05/09/2012 | CN1688586B Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors |
05/09/2012 | CN102448949A Heterocyclic compound and hematopoietic stem cell amplifier |
05/09/2012 | CN102448937A Aryl Substituted Carboxamide Derivatives As Calcium Or Sodium Channel Blockers |
05/09/2012 | CN102441099A Traditional Chinese medicine for treating goiter |
05/09/2012 | CN102441043A Chinese medicinal preparation for treating night sweating |
05/09/2012 | CN101633644B N3 alkylated benzimidazole derivatives as mek inhibitors |
05/09/2012 | CN101511796B Imidazole derivative |
05/09/2012 | CN101400333B Skin-whitening agent for external application to the skin, and method for whitening the skin |
05/09/2012 | CN101198590B Novel pyridine derivative and pyrimidine derivative (3) |
05/09/2012 | CN101133037B 6-membered heterocyclic compound and use thereof |
05/08/2012 | US8173663 Dipeptidyl peptidase inhibitors |
05/08/2012 | US8173646 FAB I inhibitors |
05/08/2012 | US8173615 TRPM-2 antisense therapy |
05/08/2012 | US8173360 Cell death inhibitor |
05/08/2012 | US8173160 Compositions comprising edible oils and vitamins and/or minerals and methods for making the compositions |
05/08/2012 | US8173142 Pharmaceutical compositions of drugs and neutralized acidic polymers |
05/08/2012 | US8173138 Stable liquid formulations of botulinum toxin |
05/08/2012 | US8173133 Acyl pseudodipeptides which carry a functionalized auxiliary arm |
05/08/2012 | US8173117 Mouse CX3C chemokine polypeptides |